3d rendering of blood vessel with too many white blood cells due to leukemia

Hematology Oncology Grand Rounds

The MUSC Hollings Cancer Center Hematology Oncology division hosts weekly Grand Rounds presentations on a variety of topics relevant to the field. Speakers include MUSC faculty as well as faculty from other institutions around the country. Select presentations are curated below.

March 2022 Grand Rounds

March 18

"Targeting the PI3K/AKT Pathway in Triple Negative Breast Cancer"

Objective: To review the current and ongoing trial data on PI3K/AKT pathway inhibition for triple negative breast cancer, including mechanisms of translating preclinical PDX model studies into clinical trials of novel therapeutics.

Nusayba A. Bagegni, M.D.
Assistant Professor of Medicine, Division of Medical Oncology
Washington University School of Medicine


March 4

"A Patient-Centered Approach to Advance Health Equity and Breast Cancer Care Delivery"

Objective: Outlining the use of technology to collect patient reported outcomes (PROs) and social determinants of health (SDOH) for breast cancer patients undergoing therapy.

Maysa M. Abu-Khalaf, M.D., MBA
Professor of Medical Oncology, Section of Solid Tumors
Director, Breast Medical Oncology Program
Co-Director, Breast Care Center
Thomas Jefferson University


February 2022 Grand Rounds

February 18

"Targeting Tumor Innate Inflammation in Pancreatic Cancer"

Objective: To present pre-clinical data on two novel therapeutic strategies in pancreatic cancer and early phase clinical trials that are being planned.

Kian H. Lim, M.D., Ph.D.
Associate Professor, Division of Oncology
Washington University School of Medicine


February 4

"Novel Immunomodulatory Approaches in AML: A New Frontier?"

Objective: Novel immune modulatory approaches that augment immune activation has clinical activity in AML and may lead to improved overall outcomes.

Joshua F. Zeidner, M.D.
Associate Professor of Medicine, Division of Hematology
Associate Chief of Research, Hematology
Section Chief, Leukemia Research
University of North Carolina Lineberger Comprehensive Cancer Center